Depression and anxiety disorders during pegylated interferon treatment in patients with chronic hepa...
Depression and anxiety disorders during pegylated interferon treatment in patients with chronic hepatitis B
About this item
Full title
Author / Creator
Publisher
Istanbul: Taylor & Francis
Journal title
Language
English
Formats
Publication information
Publisher
Istanbul: Taylor & Francis
Subjects
More information
Scope and Contents
Contents
Objectives: Interferon (IFN) treatment has many neuropsychiatric side effects such as depression and anxiety disorder. Although untreated depression is a major contributor to dosage reduction or premature discontinuation of the IFN treatment, it is found that depressive symptoms among patients undergoing hepatitis C virus (HCV) treatment are common...
Alternative Titles
Full title
Depression and anxiety disorders during pegylated interferon treatment in patients with chronic hepatitis B
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1933958689
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1933958689
Other Identifiers
ISSN
2475-0573
E-ISSN
2475-0581
DOI
10.1080/24750573.2017.1293251
